论文部分内容阅读
目的探讨呼吸(有创呼吸机)支持治疗重症肺炎的临床治疗效果。方法回顾分析2007年11月至2011年11月我科呼吸支持(有创呼吸机)治疗43例肺性脑病按是否给予呼吸支持(有创呼吸机)治疗分为治疗组和非治疗组,分析比较两组的住院天数、治愈率以及死亡率。并对结果采用统计学分析。结果按GOS标准;治疗组经过呼吸支持治疗和糖皮质激素、氨茶碱、沙丁胺醇等治疗危重支气管哮喘后的住院天数是(12.26±0.66)d明显少于非治疗组(23.12±1.40)d(P<0.05);治愈率:治疗组为95%明显高于非治疗组治愈率50%(P<0.05);病死率:治疗组为4%明显少于非治疗组病死率50%(P<0.05)。结论及时有效的呼吸支持(有创呼吸机)治疗和抗生素、氨茶碱、沙丁胺醇等治疗重症肺炎,可有效地控制病情,提高治愈率,降低住院天数和降低死亡率。
Objective To investigate the clinical effect of respiration (invasive ventilator) in the treatment of severe pneumonia. Methods Retrospective analysis of November 2007 to November 2011 my department of respiratory support (invasive ventilator) treatment of 43 cases of pulmonary encephalopathy according to whether the respiratory support (invasive ventilator) treatment is divided into treatment group and non-treatment group, analysis The days of hospitalization, cure and mortality were compared between the two groups. The results were statistically analyzed. Results According to the GOS standard, the days of hospitalization after respiratory support therapy and glucocorticoid, aminophylline and salbutamol in critically ill patients with bronchial asthma were (12.26 ± 0.66) d less than those in non-treatment group (23.12 ± 1.40) d (P <0.05). The cure rate was 95% in the treatment group, which was significantly higher than that in the non-treatment group (P <0.05). The mortality was 4% in the treatment group and less than 50% in the non-treatment group (P < 0.05). Conclusions The timely and effective respiratory support (invasive ventilator) treatment and antibiotics, aminophylline and albuterol in the treatment of severe pneumonia can effectively control the condition, improve the cure rate, reduce the length of hospital stay and reduce the mortality rate.